Cargando…

Impact of Molecular Diagnostics for Tuberculosis on Patient-Important Outcomes: A Systematic Review of Study Methodologies

BACKGROUND: Several reviews on the accuracy of Tuberculosis (TB) Nucleic Acid Amplification Tests (NAATs) have been performed but the evidence on their impact on patient-important outcomes has not been systematically reviewed. Given the recent increase in research evaluating such outcomes and the gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schumacher, Samuel G., Sohn, Hojoon, Qin, Zhi Zhen, Gore, Genevieve, Davis, J. Lucian, Denkinger, Claudia M., Pai, Madhukar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783056/ https://www.ncbi.nlm.nih.gov/pubmed/26954678 http://dx.doi.org/10.1371/journal.pone.0151073

Ejemplares similares

Impact of molecular diagnostic tests on diagnostic and treatment delays in tuberculosis: a systematic review and meta-analysis
por: Lee, Jae Hyoung, et al.
Publicado: (2022)

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016
por: Cazabon, Danielle, et al.
Publicado: (2018)

Differential yield of universal versus selective drug susceptibility testing of patients with tuberculosis in high-burden countries: a systematic review and meta-analysis
por: Svadzian, Anita, et al.
Publicado: (2020)

Advances in Molecular Diagnosis of Tuberculosis
por: MacLean, Emily, et al.
Publicado: (2020)

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?
por: Denkinger, Claudia M., et al.
Publicado: (2014)

Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis
por: Nathavitharana, Ruvandhi R., et al.
Publicado: (2017)

Informing decision-making for universal access to quality tuberculosis diagnosis in India: an economic-epidemiological model
por: Sohn, Hojoon, et al.
Publicado: (2019)

Impact of fluoroquinolone treatment on delay of tuberculosis diagnosis: A systematic review and meta-analysis
por: Hogan, Catherine A, et al.
Publicado: (2016)

Diagnostic Accuracy of Stool Xpert MTB/RIF for Detection of Pulmonary Tuberculosis in Children: a Systematic Review and Meta-analysis
por: MacLean, Emily, et al.
Publicado: (2019)

Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults
por: Steingart, Karen R, et al.
Publicado: (2013)

Innovations in Tuberculosis Diagnostics: Progress and Translational Challenges
por: Pai, Madhukar
Publicado: (2015)

The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis
por: Ricks, Saskia, et al.
Publicado: (2020)

Diagnostic accuracy of point-of-care ultrasound for pulmonary tuberculosis: A systematic review
por: Bigio, Jacob, et al.
Publicado: (2021)

Tuberculosis therapy in Mumbai: Critical importance of drug-susceptibility testing
por: Daftary, Amrita, et al.
Publicado: (2016)

Cost-effectiveness of triage testing for facility-based systematic screening of tuberculosis among Ugandan adults
por: Murray, Matthew, et al.
Publicado: (2016)

Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
por: Malhotra, Akash, et al.
Publicado: (2023)

India is well placed to scale innovations in tuberculosis diagnostics
por: Pai, Madhukar, et al.
Publicado: (2023)

Bayesian latent class analysis produced diagnostic accuracy estimates that were more interpretable than composite reference standards for extrapulmonary tuberculosis tests
por: MacLean, Emily L., et al.
Publicado: (2022)

Challenges in the Development of an Immunochromatographic Interferon-Gamma Test for Diagnosis of Pleural Tuberculosis
por: Denkinger, Claudia M., et al.
Publicado: (2013)

Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
por: Haraka, Frederick, et al.
Publicado: (2021)

Tuberculosis diagnostics: Why we need more qualitative research
por: Engel, Nora, et al.
Publicado: (2013)

How are high burden countries implementing policies and tools for latent tuberculosis infection? A survey of current practices and barriers
por: Faust, Lena, et al.
Publicado: (2020)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better?
por: Albert, Heidi, et al.
Publicado: (2016)

Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis
por: Samuels, Thomas H. A., et al.
Publicado: (2021)

Point-of-Care Testing for Infectious Diseases: Diversity, Complexity, and Barriers in Low- And Middle-Income Countries
por: Pai, Nitika Pant, et al.
Publicado: (2012)

Asia emerges as a hotbed of diagnostic innovations for tuberculosis
por: Bigio, Jacob, et al.
Publicado: (2021)

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India
por: Sarin, Sanjay, et al.
Publicado: (2019)

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF
por: Ponnudurai, Nirros, et al.
Publicado: (2018)

Adoption and uptake of the lateral flow urine LAM test in countries with high tuberculosis and HIV/AIDS burden: current landscape and barriers
por: Singhroy, Diane N., et al.
Publicado: (2020)

Modeling the impact of novel diagnostic tests on pediatric and extrapulmonary tuberculosis
por: Denkinger, Claudia M, et al.
Publicado: (2014)

Is Scale-Up Worth It? Challenges in Economic Analysis of Diagnostic Tests for Tuberculosis
por: Dowdy, David W., et al.
Publicado: (2011)

Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model
por: Moses, Mark W., et al.
Publicado: (2016)

Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study
por: Kendall, Emily A., et al.
Publicado: (2017)

Validating novel diagnostic assays for tuberculosis in the context of existing tools
por: Kerkhoff, Andrew D, et al.
Publicado: (2021)

Diagnostic Accuracy Study of a Novel Blood-Based Assay for Identification of Tuberculosis in People Living with HIV
por: Södersten, Erik, et al.
Publicado: (2021)

Promoting Affordable and Quality Tuberculosis Testing in India
por: Pai, Madhukar
Publicado: (2013)

Xpert(®) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
por: Kohli, Mikashmi, et al.
Publicado: (2018)

Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study
por: MacLean, Emily Lai-Ho, et al.
Publicado: (2023)

Time for high-burden countries to lead the tuberculosis research agenda
por: Pai, Madhukar
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_svfm6guetcol26396qac8vchrk